학술논문

Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling
Document Type
article
Source
Molecular & Cellular Oncology. 3(2)
Subject
Medical Biochemistry and Metabolomics
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Cancer
Aetiology
2.1 Biological and endogenous factors
EGF
FGF
GSK3
TGF-beta
Ras
Erk
Smad
tumor suppressor
Wnt
beta-TrCP
TGF-β
β-TrCP
Medical biochemistry and metabolomics
Oncology and carcinogenesis
Language
Abstract
The tumor suppressor Smad4/DPC4 is an essential transcription factor in the TGF-β pathway that was previously thought to function constitutively. We recently reported that Smad4 activity and stability are directly regulated by 2 major signaling pathways, RTK/MAPK and Wnt/GSK3. Here we examine the molecular, cellular, and potential therapeutic significance of these findings.